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Abstract
During 2003–2010, 555 strains isolated from sexually-infected
patients at the time of primary HIV-1 infection (PHI) were
characterized. Tree topology revealed that 11.7% of PHIs
segregated into transmission clusters. CXCR4-usage was identi-
ﬁed in 27 strains (4.9%) and was signiﬁcantly associated with
subtype B (p 0.003) and low CD4 cell count (p 0.01). In clustered
and unique PHIs, the prevalence of CXCR4-tropic strains was
1.5% and 5.3%, respectively (p 0.35). Our results are in line with
the hypothesis of a mucosal bottleneck contributing to the high
prevalence of CCR5 variants during PHI.
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During the acute phase of HIV-1 infection, CCR5-tropic
variants (‘R5 viruses’) are largely prevalent [1–3], even if both
CCR5 and CXCR4-tropic strains (‘X4 viruses’) are present in
the donor [4]. Although numerous studies have attempted to
correlate the predominance of CCR5 strains during the acute
phase of infection with a biological bottleneck inherent to the
genital mucosa [5,6], no conclusive evidence has been
provided to indicate that X4 viruses were less transmissible
[7]. Chalmet et al. recently reported that 11% of 63
transmission clusters identiﬁed in 539 recently diagnosed
patients resulted from CXCR4 transmission, and concluded
that CCR5 or CXCR4 infections resulted from a stochastic
process [8].
We previously reported the frequency of X4-strains in
patients included in the French ANRS PRIMO cohort at the
time of primary HIV-1 infection (PHI) [2,3]. We further
described that 12.7% of the patients of our cohort were
involved in clustered transmission chains and further contrib-
uted to the diffusion of the viral epidemic throughout the
whole French territory [9]. Here our aim was to compare the
frequency of X4 viruses in sexually HIV-infected patients
included in the PRIMO cohort and involved or not in clustered
transmissions.
The study population comprised 555 sexually-infected
patients enrolled in the PRIMO cohort between 2003 and
2010 at the time of PHI. PHI was deﬁned by a western blot
proﬁle compatible with ongoing seroconversion (incomplete
western blot with absence of antibodies to pol proteins) in
most patients (94%), detectable plasma HIV RNA with a
negative or weakly reactive ELISA (2%), or an interval of
<6 months between a negative and a positive ELISA result (4%)
[10]. All patients were antiretroviral-na€ıve at the time of
enrollment.
Baseline HIV-1 reverse transcriptase (RT) and V3 env
sequences were obtained from PBMC DNA [2,3,9]. Co-
receptor usage of subtype B viruses was determined with the
SVMGeno2pheno algorithm with a 5.75% false-positive rate (FPR)
cut-off. For non-B viruses, co-receptor usage was determined
using a recombinant virus phenotypic entry assay [3,11].
Finally, a population-based phylogenetic approach based on
viral RT sequences was used to identify clustered transmission
events [9]. Phylogenetic interrelationships among viral
sequences were estimated using neighbour-joining trees [12]
and maximum likelihood methods with BioEdit and MEGA4
integrated molecular evolutionary genetic analysis software
[13,14]. The existence of clusters was ascertained using the
statistical robustness of the maximum likelihood topologies
assessed by high bootstrap values (>98%) with 1000 re-
samplings and short branch lengths (genetic distances
<0.015%) [15]. Clinical features, risk factors, sexual behaviour
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and drug resistance for R5 and X4 strains were ascertained in
both clustered and non-clustered transmission events.
Comparisons between patients infected with R5 or X4
strains were made by using the chi-square or the Fisher’s exact
test for categorical variables, and the t-test or the Wilcoxon
test for continuous variables. Logistic regression was per-
formed to study the factors independently associated with an
X4 virus.
Overall, 555 patients were enrolled in our study. Their
characteristics are summarized in Table 1. Tree topology
revealed that 65/555 (11.7%) PHIs segregated into 29 different
transmission clusters (Fig. 1). Compared with unique PHI,
patients involved in clusters were more often infected with
subtype B strains (73.3% vs. 93.9%, p 0.0003). Moreover, as
recently reported in our cohort, clusters contained more men,
of younger age, belonging to Caucasian ethnicity, infected
through homosexual intercourse and with a high number of
casual sexual partnerships within the last 6 months than
unique PHI [9].
Overall, 27/555 strains (4.9%) were classiﬁed as CXCR4-
tropic (Table 1). CXCR4-usage was associated with a B
subtype, a lower CD4 cell count (p 0.01) and tended to be
associated with a higher HIV-1 RNA (p 0.09). The viral
tropism was not associated with the presence of drug
resistance (p 0.56). In clusters and unique PHI, the prevalence
of X4 strains was 1.5% (1/65) and 5.3% (26/490), respectively
(p 0.35). The only X4 virus included in a cluster was isolated
from a 43-year-old man having sex with men (MSM) infected in
2006. The second patient from the same cluster was a 37-year-
old MSM infected 34 months later with a R5 virus.
We evidenced a low proportion (4.9%) of X4 viruses at the
time of PHI, in line with previous studies [1,3,11]. We
evaluated the viral tropism of subtype B strains with the
SVMGeno2pheno algorithm using a 5.75% FPR cut-off, which has
been recently reported as highly concordant with phenotypic
assays when used in viral DNA at the time of subtype B PHI
[11]. The good speciﬁcity of this algorithm could explain the
lower frequency of subtype B X4 strains in this report
compared with our previous study, where other genotypic
rules/algorithms had been used [2].
We evidenced a low proportion of X4 strains in patients
involved in clusters. Moreover, no case of transmission of X4
viruses occurred between patients involved in the same
cluster. Interestingly, the second patient involved in the only
cluster including an X4 strain was infected with a R5 virus.
These results suggest the coexistence of both X4 and
R5 strains in the ﬁrst infected patient, with selection of a
CCR5 variant at the time of onward transmission. Another
TABLE 1. Comparison of the characteristics of patients infected with CCR5 or CXCR4-using strains at the time of primary HIV-1
infection: the ANRS PRIMO cohort 2003–2010
Total (n = 555) CCR5 (n = 528) CXCR4 (n = 27) p
Male 500 (90.1%) 474 (89.8%) 26 (96.3%) 0.50
Median age (years) (range) 35 (17–79) 35 (17–71) 38 (21–79) 0.14
Caucasian ethnicity 484 (87.2%) 458 (86.7%) 26 (96.3%) 0.23
Risk group: MSM 425 (85%) 402 (84.8%) 23 (88.5%) 0.78
Viral subtype
B 420 (75.7%) 393 (74.4%) 27 (100.0%) 0.003
CRF02 100 (18.0%) 100 (18.9%) 0 (0.0%) 0.008
Others 35 (6.3%) 35 (6.6%) 0 (0.0%)
Patient involved in a clustered transmission chain 65 (11.7%) 64 (12.1%) 1 (3.7%) 0.35
Viral resistance
 1 class of antiretrovirals (any class) 74 (13.3%) 72 (13.6%) 2 (7.4%) 0.56
Resistance to NRTI 26 (4.7%) 25 (4.7%) 1 (3.7%)
Resistance to NNRTI 28 (5.0%) 28 (5.3%) 0 (0.0%)
Resistance to PI 34 (6.1%) 33 (6.3%) 1 (3.7%)
 2 classes of antiretrovirals 13 (2.3%) 13 (2.5%) 0 (0.0%) 1.0
Median CD4 cell count (cells/mm3) (range) 518 (22–1509) 525 (44–1509) 422 (22–1083) 0.01
Median HIV RNA(log10 copies/ml) (range) 5.1 (1.8–8.1) 5.13 (1.8–8.1) 5.20 (3.3–7.9) 0.09
Year of inclusion
2007–2010 403 (72.6%) 380 (72.0%) 23 (85.2%) 0.13
Serological syphilis testing at baseline
Isolated positive TPHA 84 (15.1%) 79 (16.6%) 5 (19.2%) 0.79
Both positive TPHA and VDRL 37 (6.7%) 34 (7.2%) 3 (11.5%) 0.43
Prior sexually transmitted infectionsa 143 (27.2%) 136 (27.1%) 7 (30.4%) 0.72
Frequency of previous HIV screening
>1 test/year 207 (57.8%) 197 (58.1%) 10 (52.6%) 0.67
Number of regular sexual partnersb
0–1 323 (75.8%) 306 (75.6%) 17 (81.0%) 0.57
>1 103 (24.2%) 99 (24.4%) 4 (19.0%)
Number of casual sexual partnersb
0–1 157 (37.5%) 152 (38.3%) 5 (22.7%) 0.14
>1 262 (62.5%) 245 (61.7%) 17 (77.3%)
The total of patients for each variable does not always equal the total sample due to some missing values.
MSM, men having sex with men; NRTI, nucleoside reverse transcriptase inhibitors; NNRTI, non-nucleoside reverse transcriptase inhibitors; PI, protease inhibitors; TPHA, Treponema
palladium haemagglutination assay; VDRL, Venereal Diseases Research Laboratory test.
aUrethritis, rectitis, genital herpes infection, vulvo-vaginal candidosis, condyloma and/or syphilis.
bIn the last 6 months preceding PHI diagnosis.
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hypothesis could be an evolution from X4-tropic to R5-tropic
of the virus isolated in the ﬁrst infected patient before the time
of HIV transmission to the second patient, which occurred
34 months later. Our ﬁndings are in line with the theory of a
biological bottleneck contributing to the high prevalence of R5
variants during mucosal HIV-1 transmission [5,6]. However,
our study is limited to patients included at the time of PHI, and
rarely infected with viral subtypes that have been associated
with frequent CXCR4-usage, such as CRF01_AE or subtype D
[7], contrary to the recent Chalmet’s study, where CRF01_AE
strains were more frequently isolated. This could explain the
low number of X4 strains in both clustered and unique PHI in
the PRIMO cohort and we can not conclude deﬁnitely if
CCR5/CXCR4 infections result from a stochastic process or a
biological bottleneck. Large prospective studies of viral
tropism in transmission chains are needed to discuss these
two hypotheses.
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